{"id":"W2804839304","doi":"10.1136/jnnp-2018-anzan.85","title":"086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study","year":2018,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Relapsing remitting; Hazard ratio; Internal medicine; Proportional hazards model; Expanded Disability Status Scale; Cumulative dose; Randomized controlled trial; Confidence interval; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003508666,0.0007651132,0.002731096,0.0003652996,0.0002555438,0.001064123,0.0004826383,0.001271023,0.00417149],"category_scores_gemma":[0.003133474,0.0005476254,0.002768519,0.0003307882,0.0007067126,0.0008036026,0.0004399519,0.001215272,0.0007916915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005481531,"about_ca_system_score_gemma":0.0008565114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006637018,"about_ca_topic_score_gemma":0.001325914,"domain_scores_codex":[0.9977793,0.001530032,0.0001968135,0.00018028,0.0001721057,0.0001414551],"domain_scores_gemma":[0.9978522,0.0009211929,0.0006320112,0.0001775552,0.000128115,0.0002889568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9799024,0.001842069,0.002202037,0.0005341354,0.001805368,0.00002750295,0.0000531235,0.0001494087,0.001964044,0.00006884276,0.0003409711,0.01110998],"study_design_scores_gemma":[0.7744059,0.2034971,0.01502977,0.00009565197,0.004281543,0.00008111138,0.00005176297,0.0004641116,0.0007154461,0.000146187,0.001194103,0.00003729741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909992,0.005712326,0.0003137304,0.000362491,0.0002736769,0.0007017354,0.0006878182,0.00003587737,0.0009131205],"genre_scores_gemma":[0.9942929,0.002063682,0.0006377768,0.0003402659,0.0004967577,0.0006326648,0.0005372394,0.00001352809,0.0009853322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00417149,"threshold_uncertainty_score":0.01855588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04262455958913655,"score_gpt":0.2967030907602123,"score_spread":0.2540785311710757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}